title: [Testis cancer markers. Clinical use].
abstract: Testis tumour is relatively rare and more frequent between 15-35 years of age. The 90% of this tumour derivates from germinal cells, the remaining cases originate from stromal cells or are secondary lesions from other neoplasms. The present clinical use of serum markers, especially alfa-fetoprotein (AFP), human chorionic gonadotrophin protein (HCG) and serum lactate dehydrogenase (LDH) is examined.
authors.affiliation: I Facoltà di Medicina e Chirurgia, Divisione di Oncologia Medica, Azienda Ospedaliera S. Andrea, Rome, Italy.
authors.forename: N
authors.initials: N
authors.lastname: Salesi
authors.forename: B
authors.initials: B
authors.lastname: Di Cocco
authors.forename: F
authors.initials: F
authors.lastname: Alghisi
authors.forename: F
authors.initials: F
authors.lastname: Calabretta
authors.forename: G
authors.initials: G
authors.lastname: Bossone
mesh_terms: D014408:Biomarkers, Tumor / Q000097:blood*; D006063:Chorionic Gonadotropin / Q000097:blood*; D018237:Germinoma / Q000097:blood*; D006801:Humans; D007527:Isoenzymes / Q000097:blood*; D007770:L-Lactate Dehydrogenase / Q000097:blood*; D008297:Male; D013736:Testicular Neoplasms / Q000097:blood*; D000509:alpha-Fetoproteins / Q000032:analysis*
chemical_list: D014408:Biomarkers, Tumor; D006063:Chorionic Gonadotropin; D007527:Isoenzymes; D000509:alpha-Fetoproteins; D007770:L-Lactate Dehydrogenase